Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04812093 · ClinicalTrials.gov registry record
Spectroscopic Evaluation of Middle Ear Infection
A clinical trial of Middle Ear Infection, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT04812093 is a study of Middle Ear Infection that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 150 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT04812093, a study of Middle Ear Infection, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
Otitis media is more common in young children and it is estimated that 75% of all children experience at least one episode before the age of three. Otitis media is one of the common pediatric diagnoses and recurrent episodes account for the most commonly performed surgical procedure. Despite this a high degree of inaccuracy exists in diagnosis of this condition which depends on subjective assessment of the ear drum via direct visualization using an otoscope. Researchers can use LED-based multi wavelength light absorption and scattering measurements for the analysis of ear drum and the middle ear.
Conditions Studied
Interventions
- DEVICE Spectroscopic otoscope measurements
Study Locations (2)
California
- Children's Hospital of Orange County (CHOC) - Orange
- UCI Otolaryngology Clinic - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-02-26 |
| Est. Completion | 2028-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04812093
The ClinicalTrials.gov registry entry for NCT04812093 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Middle Ear Infection appearing as the primary indexed condition, and to 1 intervention - of which Spectroscopic otoscope measurements is the first listed.
NCT04812093 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04812093 about?
NCT04812093 is a clinical study titled "Spectroscopic Evaluation of Middle Ear Infection". Otitis media is more common in young children and it is estimated that 75% of all children experience at least one episode before the age of three. Otitis media is one of the common pediatric diagnoses and recurrent episodes account for the most commonly performed surgical procedure. Despite this a ...
What is the current status of trial NCT04812093?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-02-26. Estimated completion is 2028-12-31.
What conditions does trial NCT04812093 study?
This clinical trial studies the following conditions: Middle Ear Infection.
What interventions are being tested in trial NCT04812093?
The interventions under investigation include: Spectroscopic otoscope measurements (DEVICE).
Who is sponsoring clinical trial NCT04812093?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04812093 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Middle Ear Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.